JP2013544498A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544498A5
JP2013544498A5 JP2013530291A JP2013530291A JP2013544498A5 JP 2013544498 A5 JP2013544498 A5 JP 2013544498A5 JP 2013530291 A JP2013530291 A JP 2013530291A JP 2013530291 A JP2013530291 A JP 2013530291A JP 2013544498 A5 JP2013544498 A5 JP 2013544498A5
Authority
JP
Japan
Prior art keywords
sequence
population
adapter
genomic
bound oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013530291A
Other languages
Japanese (ja)
Other versions
JP2013544498A (en
JP5986572B2 (en
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/052645 external-priority patent/WO2012040387A1/en
Publication of JP2013544498A publication Critical patent/JP2013544498A/en
Publication of JP2013544498A5 publication Critical patent/JP2013544498A5/ja
Application granted granted Critical
Publication of JP5986572B2 publication Critical patent/JP5986572B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

標的DNAの配列決定を行うための新規アプローチを以下に提示する。本方法は、標的DNA捕捉デバイスとしての役割を果たすように、固相支持体上で汎用プライマー叢(lawn)(すなわち、ランダムに分布された少なくとも2つのプライマーを含有する)を修飾し、サンプルを大幅に操作することなく、捕捉されたDNAの直接的な配列決定を可能にすることに基づく。本方法は、関連する流体プラットフォームを用いて、標的DNAの捕捉と配列決定実験のシームレスな統合を可能にする。このアプローチは、その配列決定の可能性を維持しながら、固相支持体上でDNA捕捉基質としての役割を果たす普遍的プライマーを使用する。本方法は、配列決定のための鋳型として未処理の天然DNAを使用することができる。この方法を使用した配列決定は、必ずしも研究施設に依存するわけではない。さらに、サンプル処理の間に導入されるあらゆるバイアスが回避され、他の方法と比較してより少ない時間および低コストで実質的により小さなサンプルを分析することができる。本方法は、一本鎖および二本鎖の鋳型を分析するために使用することができる。一本鎖DNA鋳型を分析する能力は、病理学アーカイブからのホルマリン固定パラフィン包埋サンプルを使用するいくつかの配列決定用途にとって重要であり得る。同様に、一本鎖DNA鋳型による配列決定を可能にすることにより、本方法は、複雑な核酸抽出ステップ、およびDNAの二本鎖編成を保存するように設計された高価な断片化機器を必要としない。むしろ、廉価かつ効率的な溶解および加熱による断片化によってサンプルを調製することができる。単純な捕捉・配列決定アッセイは、ヒトゲノムDNAに限定されず、細菌およびウイルスのDNAおよびRNA等の他の核酸基質も分析することができる。トランスクリプトーム、非翻訳領域、およびmiRNAも、捕捉および配列決定することができる。また、ヌクレオチド配列の捕捉および配列決定、他の遺伝子特性およびエピジェネティックな特性(DNAメチル化、大きなゲノムの再編成、および遺伝子発現等)も調べることができる。本方法は、集団から合成DNAを選択するためにも用いることができる。 A novel approach for sequencing target DNA is presented below. The method modifies a universal primer lawn (ie a plex containing at least two randomly distributed primers ) on a solid support to serve as a target DNA capture device and Based on allowing direct sequencing of the captured DNA without significant manipulation. The method allows for seamless integration of target DNA capture and sequencing experiments using an associated fluid platform. This approach uses a universal primer plexus that serves as a DNA capture substrate on the solid support while maintaining its sequencing possibilities. The method can use unprocessed natural DNA as a template for sequencing. Sequencing using this method is not necessarily laboratory dependent. In addition, any bias introduced during sample processing is avoided, and substantially smaller samples can be analyzed in less time and cost compared to other methods. The method can be used to analyze single and double stranded templates. The ability to analyze single-stranded DNA templates can be important for some sequencing applications using formalin-fixed paraffin-embedded samples from pathology archives. Similarly, by allowing sequencing with single-stranded DNA templates, the method requires complex nucleic acid extraction steps and expensive fragmentation equipment designed to preserve the double-stranded organization of the DNA. And not. Rather, the sample can be prepared by inexpensive and efficient lysis and fragmentation by heating. Simple capture and sequencing assays are not limited to human genomic DNA, but can also analyze other nucleic acid substrates such as bacterial and viral DNA and RNA. Transcriptomes, untranslated regions, and miRNAs can also be captured and sequenced. Nucleotide sequence capture and sequencing, other genetic and epigenetic properties (such as DNA methylation, large genome rearrangements, and gene expression) can also be examined. The method can also be used to select synthetic DNA from a population.

一般的に、配列決定は、DNAサンプルが、配列決定システム上での分析を促進するように構造的に修飾されるプロセスとして見なされてきた。以下に記載する方法は、配列決定システムを修飾するため、サンプルを修飾して大規模に調製する必要がない。合成DNAを使用して汎用プライマーを官能基化することにより、未処理サンプルの標的遺伝子のオリゴヌクレオチドライブラリーを直接的にアッセイすることができる。非特異的捕捉を減少させるために、ブリッジ構造の形成において用いられる配列を提供する特異的DNA構成要素を経時的に導入すると、プライマー自体が修飾される。あらゆる種類のシーケンサーのための配列決定用ライブラリーの調製は、特異的二本鎖アダプター配列をDNA鋳型に付加することに依存する。捕捉オリゴヌクレオチドが固体支持体上に固定化されたアダプターとしての役割を果たしたため、アッセイのためのライブラリーの調製は、単一アダプターの付加を必要とするだけであった。これによって、サンプル処理が実質的に短縮され、クローン増幅またはゲル電気泳動に基づくサイズ分別が不要となる。特定の場合において、固体支持体上で捕捉された鋳型に第2のアダプターが付加されてもよい。本方法の特定の実施形態は、配列決定用の鋳型としての粗DNAの使用を可能にする。 In general, sequencing has been viewed as a process in which a DNA sample is structurally modified to facilitate analysis on a sequencing system. The methods described below modify the sequencing system so that the sample need not be modified and prepared on a large scale. By functionalizing the universal primer suite using synthetic DNA, an oligonucleotide library of target genes in the untreated sample can be directly assayed. In order to reduce non-specific capture, the primer plexus itself is modified when specific DNA components are introduced over time that provide the sequence used in the formation of the bridge structure. The preparation of a sequencing library for any kind of sequencer relies on the addition of specific double stranded adapter sequences to the DNA template. Since the capture oligonucleotide served as an adapter immobilized on the solid support, preparation of the library for the assay required only the addition of a single adapter. This substantially shortens sample processing and eliminates the need for size fractionation based on clonal amplification or gel electrophoresis. In certain cases, a second adapter may be added to the template captured on the solid support. Certain embodiments of the method allow the use of crude DNA as a template for sequencing.

追加の実施形態は、断片化DNAを鋳型として使用すること、および流体システムを使用して、捕捉されたDNA断片に配列決定アダプターを付加することにより、固体支持体上での配列決定のためにDNA断片の調製を可能にする方法を提供する。概念実証として、Illumina社の次世代DNAシーケンサーを使用してこれらのアプローチを開発した。プライマーの修飾およびヒトゲノム中の366ヶ所の標的部位を使用した、統合された捕捉および配列決定調製反応の結果を提示する。25分間の加熱による断片化を除いて、全てのステップをIllumina社のフローセルの固相支持体上で行うことができる。 Additional embodiments provide for sequencing on a solid support by using fragmented DNA as a template and adding a sequencing adapter to the captured DNA fragment using a fluid system. Methods are provided that allow the preparation of DNA fragments. As a proof of concept, these approaches were developed using Illumina's next generation DNA sequencer. Presents the results of integrated capture and sequencing preparation reactions using primer plex modifications and 366 target sites in the human genome. With the exception of fragmentation by heating for 25 minutes, all steps can be performed on the solid support of an Illumina flow cell.

以下に記載するデータは、アッセイのロバスト性、ならびに捕捉基質としての普遍的プライマーおよび流体システムの適用性を証明するものである。本方法がロバストに作用することを可能にする、プライマーの修飾の特有のパラメータを同定した。複雑な真核生物のゲノムに加えて、本方法は、真菌および他の微生物のゲノム、ウイルスのDNAおよびRNA、異なる源のトランスクリプトーム、ならびに合成DNAを捕捉するためにも適用できる。さらに、流体システムの固体支持体上に固定化された未変性のプライマーを「プログラミング」して、特異的な用途を実行するという概念を導入して立証した。 The data set forth below demonstrates the robustness of the assay and the applicability of universal primer plexus and fluid systems as capture substrates. We identified a unique parameter of primer plex modification that allows the method to work robustly. In addition to complex eukaryotic genomes, the method can also be applied to capture fungal and other microbial genomes, viral DNA and RNA, transcriptomes of different sources, and synthetic DNA. Furthermore, the concept of “programming” the native primer plexes immobilized on the solid support of the fluid system was introduced and proved to perform a specific application.

標的選択およびコンピュータによるOS−Seqオリゴヌクレオチドの設計 CCDS Build Release 20090902、NCBIのヒトゲノムBuild37hg19、およびdbSNP Build ID131を多型参照データセットとして使用した。遺伝子選択のために、GeneRankerアノテーションデータベースを使用して、重要性によって優先順位をつけた344個の癌遺伝子を選択した。オリゴヌクレオチドの標的特異的配列を検索するために、候補遺伝子のためのエクソンの定義をCCDSから採択した。標的エクソン(500bp未満)のほとんどにおいて、40−mer標的特異的配列が、エクソン境界の5’末端の10塩基外側にあった(図3a)。個々のプライマー・プローブを使用してエクソンの両方の鎖を標的とした。OS−Seq−366は、エクソンの隣接領域のみを覆っていた。OS−Seq−11kアッセイにおいて、エクソン領域全体が覆われるまで標的特異的配列をタイリングすることにより、500bpよりも大きいエクソンを処理した(図3b)。OS−Seq−11kのオンターゲット特異性を向上させるために、Repbaseを使用して反復性の高い配列を標的とするオリゴヌクレオチド配列を同定し、排除した。 Target selection and computational OS-Seq oligonucleotide design CCDS Build Release 2009902, NCBI human genome Build37 - hg19, and dbSNP Build ID131 were used as polymorphic reference data sets. For gene selection, the GeneRanker annotation database was used to select 344 oncogenes prioritized by importance. In order to search for target-specific sequences of oligonucleotides, exon definitions for candidate genes were adopted from CCDS. In most of the target exons (less than 500 bp), the 40-mer target specific sequence was 10 bases outside the 5 ′ end of the exon boundary (FIG. 3a). Individual primers and probes were used to target both strands of exons. OS-Seq-366 only covered the adjacent region of the exon. In the OS-Seq-11k assay, exons larger than 500 bp were processed by tiling target specific sequences until the entire exon region was covered (FIG. 3b). In order to improve the on-target specificity of OS-Seq-11k, Repbase was used to identify and eliminate oligonucleotide sequences targeting highly repetitive sequences.

フローセルプライマーの修飾によるOS−Seqプライマー・プローブの合成 Illumina社のGenome Analyzer IIx(Illumina、San Diego)システムにおいて、固相支持体(すなわち、フローセル)は、ポリアクリルアミド層上に極めて高密度でランダムに固定化された2つのプライマー(「C」および「D」)を有する。OS−Seq実験のために、Illumina社のCluster Stationを使用して「D」プライマーのサブセットを特異的に修飾した。NGSプライマー修飾の前に、133nMオリゴヌクレオチドのプールを95℃で5分間熱変性させた。熱ショック(95℃で5分間)を用いてOS−Seqオリゴヌクレオチドのコード鎖を遊離させた。第2の鎖はフローセル上で不活性であり、ハイブリダイゼーション後に洗浄されたため、さらなる鎖の精製は必要なかった。変性オリゴヌクレオチドを4xハイブリダイゼーションバッファー(20xSSC、0.2%Tween−20)で希釈した。得られた100nMオリゴヌクレオチドをフローセル修飾実験に使用した。30μlのオリゴヌクレオチド混合物をフローセルの各レーンに分注した。温度勾配(18分間で96℃から40℃)の間に、オリゴヌクレオチドは、固定化プライマー「D」に特異的にアニールした。次いで、アニールしたオリゴヌクレオチドを鋳型として「D」プライマーを伸長させるためにDNAポリメラーゼを使用した。伸長後、元のオリゴヌクレオチド鋳型を伸長させた「D」プライマーから変性させ、固相支持体から洗浄した。伸長、洗浄、および変性ステップには標準的なIllumina社のv4試薬を使用した。プライマー「D」の修飾によって、プライマー・プローブの固定化がもたらされた。 Flow cell primer modification by the synthesis Illumina's OS-Seq primer-probes flora Genome Analyzer IIx (Illumina, San Diego) in the system, the solid support (i.e., flow cell) is a very high density on the polyacrylamide layer random It has two primers ("C" and "D") immobilized on it. For OS-Seq experiments, Illumina Cluster Station was used to specifically modify a subset of “D” primers. Prior to NGS primer modification, the pool of 133 nM oligonucleotides was heat denatured at 95 ° C. for 5 minutes. The heat-shock (95 ° C. for 5 minutes) was used to release the OS-Seq oligonucleotide coding strand. Since the second strand was inactive on the flow cell and was washed after hybridization, no further strand purification was required. Denatured oligonucleotides were diluted with 4 × hybridization buffer (20 × SSC, 0.2% Tween-20). The resulting 100 nM oligonucleotide was used for flow cell modification experiments. 30 μl of the oligonucleotide mixture was dispensed into each lane of the flow cell. During the temperature gradient (96 ° C. to 40 ° C. over 18 minutes), the oligonucleotides specifically annealed to the immobilized primer “D”. DNA polymerase was then used to extend the “D” primer using the annealed oligonucleotide as a template. After extension, the original oligonucleotide template was denatured from the extended “D” primer and washed from the solid support. Standard Illumina v4 reagents were used for the extension, wash, and denaturation steps. Modification of primer “D” resulted in immobilization of the primer probe.

OS−Seqの処理は3つのステップを伴う:Illumina社の配列決定システムを、標的特異的プライマー・プローブを含むように修飾し、単一アダプターライブラリーから標的を捕捉し、固定化された断片を配列決定のために完成させる(図1b)。捕捉基質を調製するために、既存のプライマーのサブセットを標的特異的プライマー・プローブになるように修飾することにより、Illumina社のフローセルを分子的に再設計する。これらのプライマー・プローブを作製するために、オリゴヌクレオチドの複雑なプールの3’普遍的配列をフローセル上でその補体とハイブリダイズさせ、DNAポリメラーゼ伸長反応を使用して固定化プライマーを伸長させる。ランダムに配置された標的特異的プライマー・プローブのセットが得られ、フローセル表面上に固定される。65℃の高温インキュベーションの間に、プライマー・プローブは、単一アダプターゲノムDNAライブラリー内の標的相補的配列に特異的にハイブリダイズする:ハイブリダイゼーション後、次いで、プライマー・プローブは、別のDNAポリメラーゼ伸長反応のためのプライマーとして機能する。伸長ステップは、標的配列を効率的に捕捉する。伸長後、変性ステップを行い、次いで、40℃の低温ハイブリダイゼーションにより配列決定用ライブラリーアダプターをフローセル上でその補体に安定化させ、ブリッジ構造を作製する。第3のDNAポリメラーゼ伸長反応により、3’末端に追加の配列を組み込み、固相増幅が可能な2つの分子を作製する。OS−Seqに特異的な3つのステップの後、捕捉された分子をブリッジ増幅し、処理し、Illumina社のNGSシステムからの標準的な配列決定プロトコルを使用して配列決定する。OS−Seqにおける分子生物学的ステップの詳細な説明は、上記に示され、Illumina社のOS−Seq用Cluster Stationプログラムはそれに応じて変更される。 The OS-Seq process involves three steps: the Illumina sequencing system is modified to include target-specific primer probes to capture the target from a single adapter library, and the immobilized fragment is Complete for sequencing (Figure 1b). To prepare the capture substrate, the Illumina flow cell is molecularly redesigned by modifying a subset of the existing primer plexes to be target-specific primer probes. To make these primer probes, the 3 'universal sequence of a complex pool of oligonucleotides is hybridized with its complement on a flow cell and the immobilized primer is extended using a DNA polymerase extension reaction. A randomly placed set of target-specific primers and probes is obtained and immobilized on the flow cell surface. During a high temperature incubation at 65 ° C., the primer probe specifically hybridizes to the target complementary sequence in the single adapter genomic DNA library: After hybridization, the primer probe then becomes another DNA polymerase. Functions as a primer for the extension reaction. The extension step efficiently captures the target sequence. After extension, a denaturation step is performed, and then the library adapter for sequencing is stabilized to its complement on the flow cell by low-temperature hybridization at 40 ° C. to produce a bridge structure. A third DNA polymerase extension reaction incorporates an additional sequence at the 3 ′ end to produce two molecules capable of solid phase amplification. After three steps specific for OS-Seq, the captured molecules are bridge amplified, processed, and sequenced using a standard sequencing protocol from the Illumina NGS system. A detailed description of the molecular biological steps in OS-Seq is given above, and Illumina's Cluster Station program for OS-Seq will be modified accordingly.

原理の実証の証拠として、2つの捕捉アッセイを開発した。最初に、10個の癌遺伝子のエクソンに隣接する366個のOS−Seqプライマー・プローブ(OS−Seq−366)を設計した(図3)。このアッセイは、OS−Seqの方法をテストすることを企図するものであって、決定的なエクソンカバレッジをテストすることを企図するものではなかった。カラムに基づく方法を使用してOS−Seq−366オリゴヌクレオチドを合成した。次に、拡張性を証明するために、344個の癌遺伝子のエクソンを捕捉するための11,742個のプライマー・プローブを設計および合成した(OS−Seq−11k)。これらのプライマー・プローブは、エクソンカバレッジの向上のために、反復を避けて大きなエクソンにわたってタイリングした。OS−Seq−11kのハイスループットな産生のために、プログラム可能なマイクロアレイ上でオリゴヌクレオチドを合成した。これらのアレイ合成オリゴヌクレオチドは、処理のためおよびOS−Seqに十分な材料を得るために増幅を必要とする(図4)。処理後、OS−Seqオリゴヌクレオチドは、標的領域の5’末端に相補的な標的特異的40−merを含有する(図5)。また、これらのオリゴヌクレオチドは、ペアエンド配列決定プライマーのアニーリングおよびフローセル上の固定化プライマーへのハイブリダイゼーションに必要な配列を含有する。 As proof of principle, two capture assays were developed. Initially, 366 OS-Seq primer probes (OS-Seq-366) flanked by 10 oncogene exons were designed (FIG. 3). This assay was intended to test the OS-Seq method and not to test definitive exon coverage. OS-Seq-366 oligonucleotides were synthesized using a column-based method. Next, 11,742 primer probes were designed and synthesized to capture exons of 344 oncogenes to demonstrate extensibility (OS-Seq-11k). These primer probes were tiled over large exons avoiding repeats to improve exon coverage. Oligonucleotides were synthesized on programmable microarrays for high-throughput production of OS-Seq-11k. These array-synthesized oligonucleotides require amplification for processing and to obtain sufficient material for OS-Seq (Figure 4). After processing, the OS-Seq oligonucleotide contains a target specific 40-mer complementary to the 5 ′ end of the target region (FIG. 5). These oligonucleotides contain sequences necessary for hybridization to the immobilized primer flora on annealing and flow cell paired-end sequencing primers.

Claims (17)

選択された配列を捕捉および増幅する方法であって、
a)i)表面結合オリゴヌクレオチドの第1の集団およびii)表面結合オリゴヌクレオチドの第2の集団を含む叢を含む基質を得ることであって、前記表面結合オリゴヌクレオチドの第1および第2の集団のメンバーは基質の表面全体にランダムに分布され、前記基質は空間的にまたは光学的にアドレス指定された単一ヌクレオチドの集団を含まないものであることと、
b)前記表面結合オリゴヌクレオチドの第1の集団の第1のメンバーを、前記第1のメンバーとハイブリダイズする領域およびゲノム配列を含有する領域を含む合成選択オリゴヌクレオチドとハイブリダイズさせることと、
c)前記表面結合オリゴヌクレオチドの第1の集団の前記第1のメンバーを伸長させて、前記ゲノム配列に相補的な配列を含む支持体結合選択プライマーを生成することと、
d)前記支持体結合選択プライマーを、前記ゲノム配列を含む核酸断片を含む断片化されたゲノムとハイブリダイズさせることであって、前記核酸断片が5’末端にアダプターを含むものであることと、
e)前記支持体結合選択プライマーを伸長させて、ゲノム内の前記ゲノム配列に隣接する隣接配列を含有する伸長産物を生成することであって、前記伸長産物が、d)工程のアダプターに相補的な配列を3’末端に含むものであることと、
f)前記表面結合オリゴヌクレオチドの第1および第2の集団の伸長されていないメンバーを使用して、前記基質上で前記伸長産物をブリッジPCRによって増幅して、前記隣接配列を含むPCR産物を生成することであって、前記表面結合オリゴヌクレオチドの第2の集団のメンバーが、e)工程の伸長産物の3’末端のアダプターに相補的な配列とハイブリダイズし、前記隣接配列を含むPCR産物を生成すること
を含む方法。
A method for capturing and amplifying selected sequences comprising:
obtaining a substrate comprising: a) i) a first population of surface-bound oligonucleotides and ii) a plexus comprising a second population of surface-bound oligonucleotides, the first and second of said surface-bound oligonucleotides The members of the population are randomly distributed across the surface of the substrate, the substrate not including a spatially or optically addressed population of single nucleotides ;
b) hybridizing a first member of the first population of said surface bound oligonucleotides with a synthetic selection oligonucleotide comprising a region that hybridizes with said first member and a region containing a genomic sequence;
c) extending the first member of the first population of surface-bound oligonucleotides to generate a support-binding selection primer comprising a sequence complementary to the genomic sequence;
and that the d) the support-bound selection primer, the method comprising fragmenting genomic hybridized comprises a nucleic acid fragment containing the genomic sequence, wherein the nucleic acid fragment is intended to include an adapter at the 5 'end,
e) extending the support-binding selection primer to produce an extension product containing flanking sequences adjacent to the genomic sequence in the genome , wherein the extension product is complementary to the adapter of step d) Including a sequence at the 3 ′ end ,
f) Using the unextended members of the first and second populations of the surface bound oligonucleotides , amplifying the extension product on the substrate by bridge PCR to generate a PCR product comprising the flanking sequences A member of the second population of surface-bound oligonucleotides hybridizes with a sequence complementary to the adapter at the 3 ′ end of the extension product of step e), and a PCR product comprising said flanking sequences Generating .
d)工程の前記5’末端アダプターは、前記断片化されたゲノムにライゲートされた末端に配列決定プライマーのための結合部位を含む、請求項に記載の方法。 The method of claim 1 , wherein the 5 ′ end adapter of step d) comprises a binding site for a sequencing primer at the end ligated to the fragmented genome . 前記表面結合オリゴヌクレオチドの第2の集団は、
i.表面結合オリゴヌクレオチドの最初の第2の集団のメンバーを、前記表面結合オリゴヌクレオチドの第2の集団の前記メンバーとハイブリダイズする領域および前記核酸断片の配列に相補的な領域を含むオリゴヌクレオチドとハイブリダイズさせることと、
ii.前記表面結合オリゴヌクレオチドの最初の第2の集団の前記メンバーを伸長させて、前記表面結合オリゴヌクレオチドの第2の集団を生成することと、によって作製される、請求項1に記載の方法。
The second population of surface bound oligonucleotides is:
i. Hybridizing a member of the first second population of surface-bound oligonucleotides with an oligonucleotide comprising a region that hybridizes with the member of the second population of surface-bound oligonucleotides and a region that is complementary to the sequence of the nucleic acid fragment. Making it soy,
ii. The method of claim 1, wherein the method is made by extending the member of the first second population of surface-bound oligonucleotides to generate the second population of surface-bound oligonucleotides.
前記選択オリゴヌクレオチドは、前記第1のメンバーとハイブリダイズする前記領域と前記ゲノム配列を含有する前記領域との間に配列決定プライマーのための結合部位を含む、請求項1に記載の方法。 2. The method of claim 1, wherein the selection oligonucleotide comprises a binding site for a sequencing primer between the region that hybridizes to the first member and the region that contains the genomic sequence. f)工程の前記PCR産物の第1の鎖を配列決定して、前記ゲノム配列に隣接する前記配列のヌクレオチド配列の少なくとも一部を得ることをさらに含む、請求項1に記載の方法。 The method of claim 1, further comprising sequencing the first strand of the PCR product of step f) to obtain at least a portion of the nucleotide sequence of the sequence adjacent to the genomic sequence. f)工程の前記PCR産物の第2の鎖を配列決定して、前記ゲノム配列に隣接する前記配列のヌクレオチド配列の少なくとも一部を得ることをさらに含む、請求項1に記載の方法。 The method of claim 1, further comprising sequencing the second strand of the PCR product of step f) to obtain at least a portion of the nucleotide sequence of the sequence adjacent to the genomic sequence. 断片化されたゲノムを生成するために哺乳動物のゲノムを断片化することと、記断片化されたゲノムにアダプターを付加することと、前記基質に前記断片化されたゲノムを適用することと、を含む、請求項1に記載の方法。 And fragmenting the genome of a mammal to produce a fragmented genomic, and adding an adapter prior Symbol fragmented genomic, and applying the fragmented genome said substrate The method of claim 1, comprising: 前記断片化は、物理的に、化学的に、または制限酵素を使用して行われる、請求項に記載の方法。 8. The method of claim 7 , wherein the fragmentation is performed physically, chemically, or using restriction enzymes. 前記断片化は、超音波処理または剪断によって行われる、請求項に記載の方法。 The method of claim 8 , wherein the fragmentation is performed by sonication or shearing. 前記ハイブリッド形成は、複数の異なる個体からの複数の断片化されたゲノムを調製することと、プールを生成するために前記複数の断片化されたゲノムをプールすることと、前記断片化されたゲノムのプールを前記基質に適用することと、前記異なる個体の前記ゲノム配列に隣接する配列を含むPCR産物を得ることと、によって行われる、請求項に記載の方法。 The hybridizing comprises preparing a plurality of fragmented genomes from a plurality of different individuals, pooling the plurality of fragmented genomes to generate a pool, and the fragmented genomes The method of claim 7 , wherein the method comprises: applying a pool of the method to the substrate and obtaining a PCR product comprising sequences adjacent to the genomic sequence of the different individuals. 前記PCR産物の少なくとも前記第1の鎖を配列決定して、前記異なる個体の前記ゲノム配列に隣接する前記配列のヌクレオチド配列の少なくとも一部を得ることをさらに含む、請求項10に記載の方法。 11. The method of claim 10 , further comprising sequencing at least the first strand of the PCR product to obtain at least a portion of the nucleotide sequence of the sequence adjacent to the genomic sequence of the different individual. プールすることの前に、異なるアダプターが、前記異なる個体からの前記断片化されたゲノムにライゲートされ、前記アダプターは、前記PCR産物が配列決定された後に、前記アダプターをライゲートしたゲノム断片の源が同定されることを可能にするバーコード配列を含む、請求項10に記載の方法。 Prior to pooling, different adapters are ligated to the fragmented genomes from the different individuals, and the adapter is the source of the genomic fragment to which the adapters were ligated after the PCR product has been sequenced. 11. The method of claim 10 , comprising a barcode sequence that allows it to be identified. 第1のバーコード配列を含む第1のアダプターを使用して、第1の対象からの断片化されたゲノムDNAにアダプターをライゲートして、第1の産物を生成することと、
第2のバーコード配列を含む第2のアダプターを使用して、第2の対象からの断片化されたゲノムDNAにアダプターをライゲートして、第2の産物を生成することと、
前記第1および第2の産物を組み合わせて、混合鋳型を生成することと、
前記混合鋳型を使用して請求項1の方法を行って、各々が前記バーコード配列を含有する第1および第2のPCR産物を提供することと、を含む、請求項12に記載の方法。
Ligating the adapter to fragmented genomic DNA from a first subject using a first adapter comprising a first barcode sequence to produce a first product;
Ligating the adapter to fragmented genomic DNA from a second subject using a second adapter comprising a second barcode sequence to produce a second product;
Combining the first and second products to produce a mixed template;
13. The method of claim 12 , comprising performing the method of claim 1 using the mixed template to provide first and second PCR products, each containing the barcode sequence.
前記混合された鋳型は、少なくとも1,000の対象からの断片化されたゲノムDNAを含む、請求項13に記載の方法。 14. The method of claim 13 , wherein the mixed template comprises fragmented genomic DNA from at least 1,000 subjects. i.前記核酸断片を、配列決定プライマーのための部位および前記第2の表面結合オリゴヌクレオチドと同じヌクレオチド配列を含有するアダプターにライゲートすることと、
ii.前記アダプターをライゲートした断片を、前記表面結合オリゴヌクレオチドの第1の集団の第1のメンバーとハイブリダイズさせることと、
iii.前記アダプターをライゲートした断片がハイブリダイズされた前記表面結合オリゴヌクレオチドの第1の集団の前記第1のメンバーを伸長させることと、
iv.前記伸長産物の前記アダプターを含有する末端を、第2の支持体結合ポリヌクレオチドとハイブリダイズさせ、それによってブリッジを生成し、ブリッジPCRを促進することと、を含む、請求項1に記載の方法。
i. Ligating the nucleic acid fragment to an adapter containing a site for a sequencing primer and the same nucleotide sequence as the second surface-binding oligonucleotide;
ii. Hybridizing the adapter-ligated fragment with a first member of the first population of surface-bound oligonucleotides;
iii. Elongating the first member of the first population of the surface-bound oligonucleotides to which the adapter-ligated fragment is hybridized;
iv. The method of claim 1, comprising hybridizing the adapter-containing end of the extension product with a second support-binding polynucleotide, thereby generating a bridge and facilitating bridge PCR. .
前記表面結合オリゴヌクレオチドの第2の集団は、前記核酸断片の配列に相補的な領域を含むオリゴヌクレオチドを表面結合オリゴヌクレオチドの最初の第2の集団にライゲートして、前記表面結合オリゴヌクレオチドの第2の集団を生成することによって作製される、請求項1に記載の方法。 The second population of surface binding oligonucleotides ligates an oligonucleotide comprising a region complementary to the sequence of the nucleic acid fragment to the first second population of surface binding oligonucleotides, and The method of claim 1, wherein the method is made by generating two populations. 前記核酸断片は、ゲノム断片またはcDNAである、請求項1に記載の方法。 The method according to claim 1, wherein the nucleic acid fragment is a genomic fragment or cDNA.
JP2013530291A 2010-09-24 2011-09-21 Direct capture, amplification, and sequencing of target DNA using immobilized primers Active JP5986572B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38639010P 2010-09-24 2010-09-24
US61/386,390 2010-09-24
US201161485062P 2011-05-11 2011-05-11
US61/485,062 2011-05-11
PCT/US2011/052645 WO2012040387A1 (en) 2010-09-24 2011-09-21 Direct capture, amplification and sequencing of target dna using immobilized primers

Publications (3)

Publication Number Publication Date
JP2013544498A JP2013544498A (en) 2013-12-19
JP2013544498A5 true JP2013544498A5 (en) 2016-05-12
JP5986572B2 JP5986572B2 (en) 2016-09-06

Family

ID=45874160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013530291A Active JP5986572B2 (en) 2010-09-24 2011-09-21 Direct capture, amplification, and sequencing of target DNA using immobilized primers

Country Status (13)

Country Link
US (3) US9309556B2 (en)
EP (2) EP3572528A1 (en)
JP (1) JP5986572B2 (en)
KR (1) KR20130113447A (en)
CN (1) CN103228798B (en)
AU (1) AU2011305445B2 (en)
CA (1) CA2810931C (en)
IL (1) IL225109A (en)
IN (1) IN2013MN00522A (en)
MX (1) MX346956B (en)
NZ (1) NZ608313A (en)
RU (1) RU2565550C2 (en)
WO (1) WO2012040387A1 (en)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3216874A1 (en) 2008-09-05 2017-09-13 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
US8728764B2 (en) 2008-10-02 2014-05-20 Illumina Cambridge Limited Nucleic acid sample enrichment for sequencing applications
AU2010242073C1 (en) 2009-04-30 2015-12-24 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
EP2470669B1 (en) 2009-08-25 2014-06-18 Illumina, Inc. Methods for selecting and amplifying polynucleotides
PT2556171E (en) 2010-04-05 2015-12-21 Prognosys Biosciences Inc Spatially encoded biological assays
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
EP3572528A1 (en) 2010-09-24 2019-11-27 The Board of Trustees of the Leland Stanford Junior University Direct capture, amplification and sequencing of target dna using immobilized primers
US9399217B2 (en) 2010-10-04 2016-07-26 Genapsys, Inc. Chamber free nanoreactor system
US9184099B2 (en) 2010-10-04 2015-11-10 The Board Of Trustees Of The Leland Stanford Junior University Biosensor devices, systems and methods therefor
US9187783B2 (en) 2010-10-04 2015-11-17 Genapsys, Inc. Systems and methods for automated reusable parallel biological reactions
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
US8585973B2 (en) 2011-05-27 2013-11-19 The Board Of Trustees Of The Leland Stanford Junior University Nano-sensor array
US9926596B2 (en) 2011-05-27 2018-03-27 Genapsys, Inc. Systems and methods for genetic and biological analysis
CA2852665A1 (en) 2011-10-17 2013-04-25 Good Start Genetics, Inc. Analysis methods
US9206418B2 (en) 2011-10-19 2015-12-08 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
JP6193252B2 (en) 2011-12-01 2017-09-06 ジナプシス インコーポレイテッド System and method for high efficiency electronic sequencing and detection
CA2862552A1 (en) 2012-01-26 2013-08-01 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
WO2013117595A2 (en) * 2012-02-07 2013-08-15 Illumina Cambridge Limited Targeted enrichment and amplification of nucleic acids on a support
WO2013134261A1 (en) * 2012-03-05 2013-09-12 President And Fellows Of Harvard College Systems and methods for epigenetic sequencing
US8209130B1 (en) 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
US8812422B2 (en) 2012-04-09 2014-08-19 Good Start Genetics, Inc. Variant database
US10227635B2 (en) 2012-04-16 2019-03-12 Molecular Loop Biosolutions, Llc Capture reactions
WO2013169339A1 (en) 2012-05-10 2013-11-14 The General Hospital Corporation Methods for determining a nucleotide sequence
CN104619894B (en) 2012-06-18 2017-06-06 纽亘技术公司 For the composition and method of the Solid phase of unexpected nucleotide sequence
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US9092401B2 (en) 2012-10-31 2015-07-28 Counsyl, Inc. System and methods for detecting genetic variation
ES2637538T3 (en) * 2012-07-17 2017-10-13 Counsyl, Inc. System and methods for the detection of a genetic variation
US20140024541A1 (en) * 2012-07-17 2014-01-23 Counsyl, Inc. Methods and compositions for high-throughput sequencing
CN103571822B (en) * 2012-07-20 2016-03-30 中国科学院植物研究所 A kind of multipurpose DNA fragmentation enriching method analyzed for new-generation sequencing
SG11201501662TA (en) * 2012-09-04 2015-05-28 Guardant Health Inc Systems and methods to detect rare mutations and copy number variation
WO2014093330A1 (en) * 2012-12-10 2014-06-19 Clearfork Bioscience, Inc. Methods for targeted genomic analysis
EP2959016A4 (en) * 2013-02-21 2016-10-12 Toma Biosciences Inc Methods, compositions, and kits for nucleic acid analysis
US8778609B1 (en) 2013-03-14 2014-07-15 Good Start Genetics, Inc. Methods for analyzing nucleic acids
US9809852B2 (en) 2013-03-15 2017-11-07 Genapsys, Inc. Systems and methods for biological analysis
US9822408B2 (en) 2013-03-15 2017-11-21 Nugen Technologies, Inc. Sequential sequencing
WO2014197377A2 (en) 2013-06-03 2014-12-11 Good Start Genetics, Inc. Methods and systems for storing sequence read data
CN105849275B (en) 2013-06-25 2020-03-17 普罗格诺西斯生物科学公司 Method and system for detecting spatial distribution of biological targets in a sample
US9116866B2 (en) 2013-08-21 2015-08-25 Seven Bridges Genomics Inc. Methods and systems for detecting sequence variants
US9898575B2 (en) 2013-08-21 2018-02-20 Seven Bridges Genomics Inc. Methods and systems for aligning sequences
CA2927637A1 (en) 2013-10-18 2015-04-23 Seven Bridges Genomics, Inc. Methods and systems for identifying disease-induced mutations
US10832797B2 (en) 2013-10-18 2020-11-10 Seven Bridges Genomics Inc. Method and system for quantifying sequence alignment
CN105793689B (en) 2013-10-18 2020-04-17 七桥基因公司 Methods and systems for genotyping genetic samples
US11041203B2 (en) 2013-10-18 2021-06-22 Molecular Loop Biosolutions, Inc. Methods for assessing a genomic region of a subject
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
WO2015058120A1 (en) 2013-10-18 2015-04-23 Seven Bridges Genomics Inc. Methods and systems for aligning sequences in the presence of repeating elements
US9063914B2 (en) 2013-10-21 2015-06-23 Seven Bridges Genomics Inc. Systems and methods for transcriptome analysis
WO2015073711A1 (en) 2013-11-13 2015-05-21 Nugen Technologies, Inc. Compositions and methods for identification of a duplicate sequencing read
WO2015081229A2 (en) * 2013-11-26 2015-06-04 Lc Sciences Llc Selective amplification of nucleic acid sequences
EP3080300B1 (en) 2013-12-11 2020-09-02 Genapsys Inc. Systems and methods for biological analysis and computation
WO2015089496A1 (en) * 2013-12-15 2015-06-18 Academia Sinica Methods for full-length amplification of double-stranded linear nucleic acids of unknown sequences
WO2015108663A1 (en) * 2014-01-16 2015-07-23 Illumina, Inc. Amplicon preparation and sequencing on solid supports
US9677132B2 (en) * 2014-01-16 2017-06-13 Illumina, Inc. Polynucleotide modification on solid support
US9944924B2 (en) 2014-01-16 2018-04-17 Illumina, Inc. Polynucleotide modification on solid support
CN106661612A (en) 2014-01-27 2017-05-10 通用医疗公司 Methods of preparing nucleic acids for sequencing
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
WO2015161054A2 (en) * 2014-04-18 2015-10-22 Genapsys, Inc. Methods and systems for nucleic acid amplification
US20150298091A1 (en) 2014-04-21 2015-10-22 President And Fellows Of Harvard College Systems and methods for barcoding nucleic acids
US11053548B2 (en) 2014-05-12 2021-07-06 Good Start Genetics, Inc. Methods for detecting aneuploidy
ES2876432T3 (en) * 2014-05-16 2021-11-12 Illumina Inc Nucleic acid synthesis techniques
US20150361422A1 (en) * 2014-06-16 2015-12-17 Agilent Technologies, Inc. High throughput gene assembly in droplets
CN106604994B (en) * 2014-06-23 2021-12-14 通用医疗公司 Whole genome unbiased identification of DSBs by sequencing evaluation (GUIDE-Seq)
US11408024B2 (en) 2014-09-10 2022-08-09 Molecular Loop Biosciences, Inc. Methods for selectively suppressing non-target sequences
JP2017536087A (en) 2014-09-24 2017-12-07 グッド スタート ジェネティクス, インコーポレイテッド Process control to increase the robustness of genetic assays
US9558321B2 (en) 2014-10-14 2017-01-31 Seven Bridges Genomics Inc. Systems and methods for smart tools in sequence pipelines
US10066259B2 (en) 2015-01-06 2018-09-04 Good Start Genetics, Inc. Screening for structural variants
EP3530752B1 (en) 2015-04-10 2021-03-24 Spatial Transcriptomics AB Spatially distinguished, multiplex nucleic acid analysis of biological specimens
EP3283629A4 (en) 2015-04-17 2018-08-29 President and Fellows of Harvard College Barcoding systems and methods for gene sequencing and other applications
US10844428B2 (en) 2015-04-28 2020-11-24 Illumina, Inc. Error suppression in sequenced DNA fragments using redundant reads with unique molecular indices (UMIS)
US10275567B2 (en) 2015-05-22 2019-04-30 Seven Bridges Genomics Inc. Systems and methods for haplotyping
JP6890096B2 (en) * 2015-06-02 2021-06-18 バイオファイアー・ディフェンス・エルエルシー Sequence from sample
RU2604198C1 (en) * 2015-06-22 2016-12-10 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Method of producing heterogeneous set of single-chain dna fragments for multiplex genetic analysis
US10793895B2 (en) 2015-08-24 2020-10-06 Seven Bridges Genomics Inc. Systems and methods for epigenetic analysis
US10584380B2 (en) 2015-09-01 2020-03-10 Seven Bridges Genomics Inc. Systems and methods for mitochondrial analysis
US10724110B2 (en) 2015-09-01 2020-07-28 Seven Bridges Genomics Inc. Systems and methods for analyzing viral nucleic acids
CA3005985A1 (en) * 2015-09-09 2017-03-16 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics of infectious disease and other health conditions associated with antibiotic usage
CN111154754B (en) 2015-09-18 2024-02-02 苏州新波生物技术有限公司 Probe set for analyzing DNA sample and method for using the same
US11347704B2 (en) 2015-10-16 2022-05-31 Seven Bridges Genomics Inc. Biological graph or sequence serialization
KR101651817B1 (en) * 2015-10-28 2016-08-29 대한민국 Primer set for Preparation of NGS library and Method and Kit for making NGS library using the same
MX2018005858A (en) 2015-11-11 2019-02-20 Resolution Bioscience Inc High efficiency construction of dna libraries.
US10364468B2 (en) 2016-01-13 2019-07-30 Seven Bridges Genomics Inc. Systems and methods for analyzing circulating tumor DNA
US10460829B2 (en) 2016-01-26 2019-10-29 Seven Bridges Genomics Inc. Systems and methods for encoding genetic variation for a population
US10262102B2 (en) 2016-02-24 2019-04-16 Seven Bridges Genomics Inc. Systems and methods for genotyping with graph reference
JP7086855B2 (en) * 2016-03-28 2022-06-20 エヌキャン ジェノミクス, インコーポレイテッド Linked double chain target capture
US10961573B2 (en) 2016-03-28 2021-03-30 Boreal Genomics, Inc. Linked duplex target capture
US11708574B2 (en) 2016-06-10 2023-07-25 Myriad Women's Health, Inc. Nucleic acid sequencing adapters and uses thereof
WO2018017884A1 (en) 2016-07-20 2018-01-25 Genapsys, Inc. Systems and methods for nucleic acid sequencing
CN109642219B (en) 2016-08-05 2021-02-26 生物辐射实验室股份有限公司 Second chain guide
BR112019003704A2 (en) 2016-08-25 2019-05-28 Resolution Bioscience Inc Methods for Detecting Genomic Copy Changes in DNA Samples
US11250931B2 (en) 2016-09-01 2022-02-15 Seven Bridges Genomics Inc. Systems and methods for detecting recombination
EP3933039A1 (en) 2016-09-15 2022-01-05 ArcherDX, LLC Methods of nucleic acid sample preparation
JP6997773B2 (en) 2016-09-15 2022-01-18 アーチャーディーエックス, エルエルシー Method for preparing nucleic acid sample for analysis of cell-free DNA
CA3037366A1 (en) 2016-09-29 2018-04-05 Myriad Women's Health, Inc. Noninvasive prenatal screening using dynamic iterative depth optimization
JP7048609B2 (en) 2016-12-09 2022-04-05 ボリアル ジェノミクス, インコーポレイテッド Linked ligation
GB201704754D0 (en) * 2017-01-05 2017-05-10 Illumina Inc Kinetic exclusion amplification of nucleic acid libraries
RU2022101605A (en) 2017-01-18 2022-03-25 Иллюмина, Инк. METHODS AND SYSTEMS FOR OBTAINING SETS OF UNIQUE MOLECULAR INDICES WITH HETEROGENEOUS LENGTH OF MOLECULES AND CORRECTION OF THEIR ERRORS
WO2018144216A1 (en) 2017-01-31 2018-08-09 Counsyl, Inc. Methods and compositions for enrichment of target polynucleotides
WO2018144217A1 (en) 2017-01-31 2018-08-09 Counsyl, Inc. Methods and compositions for enrichment of target polynucleotides
US10787699B2 (en) * 2017-02-08 2020-09-29 Microsoft Technology Licensing, Llc Generating pluralities of primer and payload designs for retrieval of stored nucleotides
WO2018161019A1 (en) * 2017-03-03 2018-09-07 Counsyl, Inc. Methods for optimizing direct targeted sequencing
CA3057589A1 (en) 2017-03-24 2018-09-27 Counsyl, Inc. Copy number variant caller
US11447818B2 (en) 2017-09-15 2022-09-20 Illumina, Inc. Universal short adapters with variable length non-random unique molecular identifiers
SG11202002516WA (en) 2017-09-21 2020-04-29 Genapsys Inc Systems and methods for nucleic acid sequencing
CN118048419A (en) * 2017-10-04 2024-05-17 生捷科技控股公司 Method and system for enzymatic synthesis of oligonucleotides
US11725228B2 (en) 2017-10-11 2023-08-15 The General Hospital Corporation Methods for detecting site-specific and spurious genomic deamination induced by base editing technologies
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
EP3749779A4 (en) * 2018-02-07 2021-11-24 Nugen Technologies, Inc. Library preparation
AU2019256287A1 (en) 2018-04-17 2020-11-12 The General Hospital Corporation Sensitive in vitro assays for substrate preferences and sites of nucleic acid binding, modifying, and cleaving agents
WO2020018824A1 (en) * 2018-07-19 2020-01-23 Ultima Genomics, Inc. Nucleic acid clonal amplification and sequencing methods, systems, and kits
CN113728114A (en) * 2018-10-09 2021-11-30 台湾地区“中央研究院” Digital polymerase chain reaction method for detecting nucleic acid in sample
US20220025354A1 (en) * 2018-12-14 2022-01-27 Bgi Shenzhen Nucleic acid synthesis and purification device, use thereof, and nucleic acid synthesis and purification method
CN112654714A (en) * 2018-12-17 2021-04-13 伊卢米纳剑桥有限公司 Primer oligonucleotides for sequencing
US11473136B2 (en) 2019-01-03 2022-10-18 Ncan Genomics, Inc. Linked target capture
US11649485B2 (en) 2019-01-06 2023-05-16 10X Genomics, Inc. Generating capture probes for spatial analysis
US11926867B2 (en) 2019-01-06 2024-03-12 10X Genomics, Inc. Generating capture probes for spatial analysis
WO2020237010A1 (en) * 2019-05-21 2020-11-26 Academia Sinica Method for amplifying and detecting ribonucleic acid (rna) fragments
US11639521B2 (en) * 2019-06-03 2023-05-02 The Chinese University Of Hong Kong Method for determining the copy number of a tandem repeat sequence
CN112342269B (en) * 2019-08-09 2023-12-05 深圳市真迈生物科技有限公司 Method for capturing nucleic acid molecules and application thereof
US11795495B1 (en) * 2019-10-02 2023-10-24 FOXO Labs Inc. Machine learned epigenetic status estimator
US11821035B1 (en) 2020-01-29 2023-11-21 10X Genomics, Inc. Compositions and methods of making gene expression libraries
EP4097231A4 (en) * 2020-01-31 2024-04-03 Agilent Technologies Inc Systems and methods for targeted nucleic acid capture
CA3145539A1 (en) * 2020-02-26 2021-09-02 Illumina, Inc. Kits for genotyping
EP4150126A2 (en) * 2020-05-12 2023-03-22 Singular Genomics Systems, Inc. Nucleic acid amplification methods
WO2022015600A2 (en) 2020-07-13 2022-01-20 Singular Genomics Systems, Inc. Methods of sequencing complementary polynucleotides
CN111676276A (en) * 2020-07-13 2020-09-18 湖北伯远合成生物科技有限公司 Method for rapidly and accurately determining gene editing mutation condition and application thereof
CA3187366A1 (en) * 2020-07-31 2022-02-03 Arc Bio, Llc Systems, methods, and media for determining relative quality of oligonucleotide preparations
WO2022055969A1 (en) * 2020-09-08 2022-03-17 Seqwell, Inc. Sequencing oligonucleotides and methods of use thereof
RU2748380C1 (en) * 2020-11-10 2021-05-25 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) SET OF OLIGONUCLEOTIDE PRIMERS AND METHOD FOR GENOTYPING SINGLE NUCLEOTIDE POLYMORPHISM rs8065080 IN HUMAN TRPV1 GENE
CN112837749B (en) * 2021-02-01 2021-11-26 北京百奥纳芯生物科技有限公司 Optimization method of gene chip probe for cancer screening
AU2022313872A1 (en) * 2021-07-20 2024-02-22 Freenome Holdings, Inc. Compositions and methods for improved 5-hydroxymethylated cytosine resolution in nucleic acid sequencing
CN114621307A (en) * 2022-04-12 2022-06-14 中国科学院苏州生物医学工程技术研究所 Oligonucleotide space coordinate coding method and microfluidic device thereof

Family Cites Families (271)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3575220A (en) 1968-08-12 1971-04-20 Scientific Industries Apparatus for dispensing liquid sample
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4351760A (en) 1979-09-07 1982-09-28 Syva Company Novel alkyl substituted fluorescent compounds and polyamino acid conjugates
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4739044A (en) 1985-06-13 1988-04-19 Amgen Method for derivitization of polynucleotides
US4757141A (en) 1985-08-26 1988-07-12 Applied Biosystems, Incorporated Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
US6127155A (en) 1986-08-22 2000-10-03 Roche Molecular Systems, Inc. Stabilized thermostable nucleic acid polymerase compositions containing non-ionic polymeric detergents
US5618711A (en) 1986-08-22 1997-04-08 Hoffmann-La Roche Inc. Recombinant expression vectors and purification methods for Thermus thermophilus DNA polymerase
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US6090591A (en) 1987-07-31 2000-07-18 The Board Of Trustees Of The Leland Stanford Junior University Selective amplification of target polynucleotide sequences
US5231191A (en) 1987-12-24 1993-07-27 Applied Biosystems, Inc. Rhodamine phosphoramidite compounds
US4997928A (en) 1988-09-15 1991-03-05 E. I. Du Pont De Nemours And Company Fluorescent reagents for the preparation of 5'-tagged oligonucleotides
AU4128089A (en) 1988-09-15 1990-03-22 Rorer International (Overseas) Inc. Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US7223833B1 (en) 1991-05-24 2007-05-29 Isis Pharmaceuticals, Inc. Peptide nucleic acid conjugates
US5981179A (en) 1991-11-14 1999-11-09 Digene Diagnostics, Inc. Continuous amplification reaction
CA2134552A1 (en) 1992-04-27 1993-11-11 George D. Sorenson Detection of gene sequences in biological fluids
ATE208658T1 (en) 1993-07-28 2001-11-15 Pe Corp Ny APPARATUS AND METHOD FOR NUCLEIC ACID DUPLICATION
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
CH686982A5 (en) 1993-12-16 1996-08-15 Maurice Stroun Method for diagnosis of cancers.
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5604097A (en) 1994-10-13 1997-02-18 Spectragen, Inc. Methods for sorting polynucleotides using oligonucleotide tags
US5585069A (en) 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US6312894B1 (en) 1995-04-03 2001-11-06 Epoch Pharmaceuticals, Inc. Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
US5750341A (en) 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
US5789206A (en) 1995-07-07 1998-08-04 Myriad Genetics, Inc. Method for ligating adaptors to nucleic acids which methods are useful for obtaining the ends of genes
US5773258A (en) 1995-08-25 1998-06-30 Roche Molecular Systems, Inc. Nucleic acid amplification using a reversibly inactivated thermostable enzyme
NO954667D0 (en) 1995-11-17 1995-11-17 Dagfinn Oegreid Method for detecting Ki-ras mutations
AU2324997A (en) 1996-03-15 1997-10-01 Penn State Research Foundation, The Detection of extracellular tumor-associated nucleic acid in blood plasma or ser um using nucleic acid amplification assays
JP2000505312A (en) 1996-03-18 2000-05-09 モレキュラー バイオロジー リソーシーズ,インコーポレイテッド Target nucleic acid sequence amplification
US6759217B2 (en) 1996-03-26 2004-07-06 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
SE9602829D0 (en) 1996-07-19 1996-07-19 Yngve Johnsson Procedure and apparatus for payment processing and means of payment
US5998140A (en) 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
US6262242B1 (en) 1997-01-30 2001-07-17 Board Of Regents, The University Of Texas System Tumor suppressor designated TS10Q23.3
US6482795B1 (en) 1997-01-30 2002-11-19 Myriad Genetics, Inc. Tumor suppressor designated TS10q23.3
AU6846698A (en) 1997-04-01 1998-10-22 Glaxo Group Limited Method of nucleic acid amplification
US6143496A (en) 1997-04-17 2000-11-07 Cytonix Corporation Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
JPH10341047A (en) 1997-06-06 1998-12-22 Sony Corp Magnetic tunnel device
DE69826697T2 (en) 1997-07-07 2006-02-16 Medical Research Council IN VITRO SELECTION METHOD
US6008002A (en) 1997-09-29 1999-12-28 Bodey; Bela Immunomagnetic detection and isolation of cancer cells
US5948902A (en) 1997-11-20 1999-09-07 South Alabama Medical Science Foundation Antisense oligonucleotides to human serine/threonine protein phosphatase genes
AU760560B2 (en) 1998-02-12 2003-05-15 Board Of Regents, The University Of Texas System Methods and reagents for the rapid and efficient isolation of circulating cancer cells
JPH11355695A (en) 1998-06-10 1999-12-24 Sony Corp Video signal processor
DE19833738A1 (en) 1998-07-27 2000-02-03 Michael Giesing Process for isolating cancer cells from cell-containing body fluids and kits for performing this process
US6787308B2 (en) 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
US6204375B1 (en) 1998-07-31 2001-03-20 Ambion, Inc. Methods and reagents for preserving RNA in cell and tissue samples
AR021833A1 (en) 1998-09-30 2002-08-07 Applied Research Systems METHODS OF AMPLIFICATION AND SEQUENCING OF NUCLEIC ACID
US6086740A (en) 1998-10-29 2000-07-11 Caliper Technologies Corp. Multiplexed microfluidic devices and systems
US6429027B1 (en) 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
WO2000040758A2 (en) 1999-01-06 2000-07-13 Hyseq Inc. Enhanced sequencing by hybridization using pools of probes
US6565727B1 (en) 1999-01-25 2003-05-20 Nanolytics, Inc. Actuators for microfluidics without moving parts
US9534254B1 (en) 1999-02-02 2017-01-03 Abbott Molecular Inc. Patient stratification for cancer therapy based on genomic DNA microarray analysis
US6395481B1 (en) 1999-02-16 2002-05-28 Arch Development Corp. Methods for detection of promoter polymorphism in a UGT gene promoter
US6410231B1 (en) 1999-02-26 2002-06-25 Incyte Genomics, Inc. SNP detection
US7324926B2 (en) 1999-04-09 2008-01-29 Whitehead Institute For Biomedical Research Methods for predicting chemosensitivity or chemoresistance
US20010034023A1 (en) 1999-04-26 2001-10-25 Stanton Vincent P. Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing
US6492161B1 (en) 1999-06-02 2002-12-10 Prokaria Ltd. Bacteriophage RM 378 of a thermophilic host organism
US6300070B1 (en) * 1999-06-04 2001-10-09 Mosaic Technologies, Inc. Solid phase methods for amplifying multiple nucleic acids
US6524456B1 (en) 1999-08-12 2003-02-25 Ut-Battelle, Llc Microfluidic devices for the controlled manipulation of small volumes
ATE503843T1 (en) 1999-09-01 2011-04-15 Whitehead Biomedical Inst WHOLE CHROMOSOME ANALYSIS OF PROTEIN-DNA INTERACTIONS
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7205105B2 (en) 1999-12-08 2007-04-17 Epoch Biosciences, Inc. Real-time linear detection probes: sensitive 5′-minor groove binder-containing probes for PCR analysis
WO2001053460A1 (en) 2000-01-21 2001-07-26 Variagenics, Inc. Identification of genetic components of drug response
EP1356289A2 (en) 2000-01-26 2003-10-29 20/20 Genomics, LLC A system for developing assays for personalized medicine
AU2001241939A1 (en) 2000-02-28 2001-09-12 Maxygen, Inc. Single-stranded nucleic acid template-mediated recombination and nucleic acid fragment isolation
ES2391213T3 (en) 2000-03-01 2012-11-22 Epoch Biosciences, Inc. Modified oligonucleotides for mismatch discrimination
US20020120409A1 (en) 2000-05-19 2002-08-29 Affymetrix, Inc. Methods for gene expression analysis
WO2001096382A2 (en) 2000-06-15 2001-12-20 Prokaria Ehf. Thermostable cellulase
US6773566B2 (en) 2000-08-31 2004-08-10 Nanolytics, Inc. Electrostatic actuators for microfluidics and methods for using same
WO2002023163A1 (en) 2000-09-15 2002-03-21 California Institute Of Technology Microfabricated crossflow devices and methods
AU2001292802A1 (en) 2000-09-19 2002-04-02 Dana-Farber Cancer Institute Inc. Genetic markers for tumors
AU2002246612B2 (en) 2000-10-24 2007-11-01 The Board Of Trustees Of The Leland Stanford Junior University Direct multiplex characterization of genomic DNA
US20050021240A1 (en) 2000-11-02 2005-01-27 Epigenomics Ag Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA
WO2002036761A2 (en) 2000-11-03 2002-05-10 Dana Farber Cancer Institute Compositions and methods for the diagnosis of cancer
EP1207209A3 (en) 2000-11-09 2002-09-11 Agilent Technologies, Inc. (a Delaware corporation) Methods using arrays for detection of single nucleotide polymorphisms
CN1488002A (en) 2000-12-01 2004-04-07 ��˹��ŵ�� Method of determining epidermal growth factor receptor and HER2-Neu gene expression and correlation of levels thereof with survival rates
US6582919B2 (en) 2001-06-11 2003-06-24 Response Genetics, Inc. Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
US6958217B2 (en) 2001-01-24 2005-10-25 Genomic Expression Aps Single-stranded polynucleotide tags
US20020115073A1 (en) 2001-02-16 2002-08-22 Nickolas Papadopoulos Genome-based personalized medicine
DE60211857T2 (en) 2001-02-23 2006-12-21 Japan Science And Technology Agency, Kawaguchi METHOD FOR PRODUCING AN EMULSION AND DEVICE THEREFOR
US6632611B2 (en) 2001-07-20 2003-10-14 Affymetrix, Inc. Method of target enrichment and amplification
US20040110193A1 (en) 2001-07-31 2004-06-10 Gene Logic, Inc. Methods for classification of biological data
US20030165940A1 (en) 2001-12-06 2003-09-04 The Johns Hopkins University Disease detection by digital protein truncation assays
WO2003054149A2 (en) 2001-12-07 2003-07-03 University Of Massachusetts Targeted genetic risk-stratification using microarrays
US6949342B2 (en) 2001-12-21 2005-09-27 Whitehead Institute For Biomedical Research Prostate cancer diagnosis and outcome prediction by expression analysis
NZ532780A (en) 2001-12-21 2006-10-27 Wellcome Trust Isolated naturally occurring mutant human B-Raf polypeptides and nucleic acids encoding them
US7730063B2 (en) 2002-12-10 2010-06-01 Asset Trust, Inc. Personalized medicine service
US7473534B2 (en) 2002-03-01 2009-01-06 Siemens Healthcare Diagnostics Inc. Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte, alone or in combination with other analytes, in body fluid samples
AU2003213836A1 (en) 2002-03-11 2003-09-29 Epoch Biosciences, Inc. Negatively charged minor groove binders
US7427480B2 (en) 2002-03-26 2008-09-23 Perlegen Sciences, Inc. Life sciences business systems and methods
US7138226B2 (en) 2002-05-10 2006-11-21 The University Of Miami Preservation of RNA and morphology in cells and tissues
AU2003249681A1 (en) * 2002-05-31 2003-12-19 Diversa Corporation Multiplexed systems for nucleic acid sequencing
US9388459B2 (en) * 2002-06-17 2016-07-12 Affymetrix, Inc. Methods for genotyping
TWI266907B (en) 2002-07-24 2006-11-21 Nitto Denko Corp Polarizing device, optical thin film using the same, and image display device using the same
AU2003275138A1 (en) 2002-09-19 2004-04-08 Applied Biosystems, Llc. Methods and compositions for detecting targets
WO2004027054A1 (en) 2002-09-20 2004-04-01 Prokaria Ehf. Thermostable rna ligase from thermus phage
US6911132B2 (en) 2002-09-24 2005-06-28 Duke University Apparatus for manipulating droplets by electrowetting-based techniques
JP4606879B2 (en) 2002-11-15 2011-01-05 ジェノミック ヘルス, インコーポレイテッド Gene expression profiling of EGFR positive cancer
US8275554B2 (en) 2002-12-20 2012-09-25 Caliper Life Sciences, Inc. System for differentiating the lengths of nucleic acids of interest in a sample
AU2003302770B2 (en) 2002-12-20 2007-07-12 Caliper Life Sciences, Inc. Single molecule amplification and detection of DNA
US20040137539A1 (en) 2003-01-10 2004-07-15 Bradford Sherry A. Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies
WO2004069849A2 (en) 2003-01-29 2004-08-19 454 Corporation Bead emulsion nucleic acid amplification
US20090124514A1 (en) * 2003-02-26 2009-05-14 Perlegen Sciences, Inc. Selection probe amplification
US7041481B2 (en) 2003-03-14 2006-05-09 The Regents Of The University Of California Chemical amplification based on fluid partitioning
US20080044813A1 (en) 2003-03-20 2008-02-21 Kristian Jansson Amp Ligation Assay (Ala)
WO2004092333A2 (en) 2003-04-09 2004-10-28 Omicia Inc. Methods of selection, reporting and analysis of genetic markers using broad based genetic profiling applications
AU2004235298A1 (en) 2003-04-25 2004-11-11 Janssen Pharmaceutica N.V. Preservation of RNA in a biological sample
EP1631689A2 (en) 2003-05-28 2006-03-08 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
RU2392324C2 (en) * 2003-09-18 2010-06-20 Симфоген А/С Concerned sequences linkage method
WO2005040400A2 (en) 2003-10-24 2005-05-06 Mmi Genomics, Inc. Methods and systems for inferring traits to manage non-beef livestock
SI1687609T1 (en) 2003-10-28 2015-03-31 Epoch Biosciences, Inc. Fluorescent probes for dna detection by hybridization with improved sensitivity and low background
EP1756137A4 (en) 2003-11-05 2007-10-31 Univ Texas Diagnostic and therapeutic methods and compositions involving pten and breast cancer
WO2005049849A2 (en) 2003-11-14 2005-06-02 Integrated Dna Technologies, Inc. Fluorescence quenching azo dyes, their methods of preparation and use
US20050181377A1 (en) 2004-02-13 2005-08-18 Markovic Svetomir N. Targeted cancer therapy
US20060195266A1 (en) 2005-02-25 2006-08-31 Yeatman Timothy J Methods for predicting cancer outcome and gene signatures for use therein
US20060046258A1 (en) 2004-02-27 2006-03-02 Lapidus Stanley N Applications of single molecule sequencing
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
JP2007527241A (en) 2004-03-01 2007-09-27 ユニバーシティ オブ シカゴ Polymorphisms in the epidermal growth factor receptor gene promoter
US7601821B2 (en) 2004-03-24 2009-10-13 Applied Biosystems, Llc Encoding and decoding reactions for determining target molecules
BRPI0508286B8 (en) 2004-03-31 2021-05-25 Dana Farber Cancer Inst Inc method to determine the likelihood of efficacy of an egfr tyrosine kinase inhibitor to treat cancer, use of an egfr tyrosine kinase inhibitor, probe, kit, and, primer pair
US20080176209A1 (en) 2004-04-08 2008-07-24 Biomatrica, Inc. Integration of sample storage and sample management for life science
ES2550614T3 (en) 2004-04-09 2015-11-11 Genomic Health, Inc. Gene expression markers to predict the response to chemotherapy
US20090246756A1 (en) 2004-05-06 2009-10-01 Prokaria Ehe Thermostable polypeptide having polynucleotide kinase activity and/or phosphatase activity
US7622281B2 (en) * 2004-05-20 2009-11-24 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for clonal amplification of nucleic acid
US7932026B2 (en) 2004-06-04 2011-04-26 Genentech, Inc. EGFR mutations
US7329495B2 (en) 2004-06-09 2008-02-12 Board Of Regents, The University Of Texas System Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors
US20060115827A1 (en) 2004-07-01 2006-06-01 University Of Southern California Genetic markers for predicting disease and treatment outcome
EP1784646B1 (en) 2004-08-11 2012-06-13 Albert Einstein College Of Medicine Of Yeshiva University Method for identifying metastasis in motile cells
ES2359322T3 (en) 2004-10-18 2011-05-20 Brandeis University PROCEDURE FOR AMPLIFICATION OF NUCLEIC ACIDS.
US7700283B2 (en) 2004-10-21 2010-04-20 New England Biolabs, Inc. Repair of nucleic acids for improved amplification
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
US20060278241A1 (en) 2004-12-14 2006-12-14 Gualberto Ruano Physiogenomic method for predicting clinical outcomes of treatments in patients
US20060184489A1 (en) 2004-12-17 2006-08-17 General Electric Company Genetic knowledgebase creation for personalized analysis of medical conditions
US20060188909A1 (en) 2005-01-21 2006-08-24 Medical College Of Ohio Business methods for assessing nucleic acids
US7442507B2 (en) 2005-01-24 2008-10-28 New York University School Of Medicine Methods for detecting circulating mutant BRAF DNA
BRPI0607213B1 (en) 2005-01-28 2017-04-04 Univ Duke droplet handling apparatus on a printed circuit board
BRPI0609615A2 (en) 2005-04-01 2010-04-27 Amgen Inc methods of predicting the efficacy of egfr-specific binding agent treatment in treating egfr-related cancer in a subject, treating the same and determining the effectiveness of treatment in a patient
ES2313143T3 (en) 2005-04-06 2009-03-01 Maurice Stroun METHOD FOR THE CANCER DIAGNOSIS THROUGH CIRCULATING DNA AND RNA DETECTION.
US20090269344A1 (en) 2005-04-14 2009-10-29 Salvatore Siena Anti-EGFR antibody therapy based on an increased copy number of the EGFR gene in tumor tissues
JP4547301B2 (en) 2005-05-13 2010-09-22 株式会社日立ハイテクノロジーズ Liquid transport device and analysis system
US20070020657A1 (en) 2005-05-20 2007-01-25 Grebe Stefan K Methods for detecting circulating tumor cells
EP1885878B1 (en) 2005-05-31 2010-08-11 Dako Denmark A/S Compositions and methods for predicting outcome of treatment
ES2398709T5 (en) 2005-06-28 2017-04-18 Genentech, Inc. Mutations in EGFR and KRAS to predict a patient's response to treatment with EGFR inhibitors
GB0514909D0 (en) * 2005-07-20 2005-08-24 Solexa Ltd Methods of nucleic acid amplification and sequencing
US7993821B2 (en) 2005-08-11 2011-08-09 University Of Washington Methods and apparatus for the isolation and enrichment of circulating tumor cells
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
JP2009508495A (en) 2005-09-16 2009-03-05 454 ライフ サイエンシーズ コーポレイション cDNA library preparation
EP1946114A4 (en) 2005-09-21 2010-05-26 Ccc Diagnostics Llc Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac)
US20070172844A1 (en) 2005-09-28 2007-07-26 University Of South Florida Individualized cancer treatments
PT1948816E (en) 2005-10-24 2012-03-19 Univ Johns Hopkins Improved methods for beaming
DK1966394T3 (en) 2005-12-22 2012-10-29 Keygene Nv Improved transcript profiling strategies using high throughput sequencing technologies
EP2298438A1 (en) 2006-02-07 2011-03-23 Stokes Bio Limited A microfluidic droplet queuing network
US20080280331A1 (en) 2006-02-07 2008-11-13 Stokes Bio Limited Microfluidic Analysis System
US20100304446A1 (en) 2006-02-07 2010-12-02 Stokes Bio Limited Devices, systems, and methods for amplifying nucleic acids
WO2007095644A2 (en) 2006-02-16 2007-08-23 Ventana Medical Systems, Inc. Reagents and methods for cancer prognosis and pathological staging
WO2007100243A1 (en) 2006-03-01 2007-09-07 Keygene N.V. High throughput sequence-based detection of snps using ligation assays
US8086005B2 (en) 2006-03-08 2011-12-27 Olympus Medical Systems Corp. Medical image processing apparatus and medical image processing method
WO2007106432A2 (en) 2006-03-10 2007-09-20 George Mason Intellectual Properties, Inc. Egf receptor phosphorylation status for disease treatment
WO2007109571A2 (en) 2006-03-17 2007-09-27 Prometheus Laboratories, Inc. Methods of predicting and monitoring tyrosine kinase inhibitor therapy
US20070231823A1 (en) 2006-03-23 2007-10-04 Mckernan Kevin J Directed enrichment of genomic DNA for high-throughput sequencing
TW200806789A (en) 2006-03-27 2008-02-01 Globeimmune Inc RAS mutation and compositions and methods related thereto
TWI395754B (en) 2006-04-24 2013-05-11 Amgen Inc Humanized c-kit antibody
WO2007133506A2 (en) 2006-05-09 2007-11-22 University Of Louisville Research Foundation , Inc. Personalized medicine management software
EP2047910B1 (en) 2006-05-11 2012-01-11 Raindance Technologies, Inc. Microfluidic device and method
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
IL282783B2 (en) 2006-05-18 2023-09-01 Caris Mpi Inc System and method for determining individualized medical intervention for a disease state
US20080090239A1 (en) 2006-06-14 2008-04-17 Daniel Shoemaker Rare cell analysis using sample splitting and dna tags
WO2008015396A2 (en) 2006-07-31 2008-02-07 Solexa Limited Method of library preparation avoiding the formation of adaptor dimers
US20080065411A1 (en) 2006-09-08 2008-03-13 Diaceutics Method and system for developing a personalized medicine business plan
CA2662508A1 (en) 2006-09-19 2008-07-10 Novartis Ag Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors
ZA200902543B (en) 2006-09-28 2010-07-28 Stokes Bio Ltd A QPCR analysis apparatus
EP2076609A1 (en) 2006-10-10 2009-07-08 Illumina Inc. Compositions and methods for representational selection of nucleic acids fro complex mixtures using hybridization
BRPI0718322A2 (en) 2006-10-27 2013-11-26 Decode Genetics METHODS FOR DIAGNOSISING A SUSTAINABILITY FOR CANCER IN A HUMAN INDIVIDUAL, TO IDENTIFY A MARKER FOR USE IN THE ASSESSMENT OF CANCER SUSCETIBILITY, TO GENOTYPE A NUCLEIC ACID SAMPLE TO EVALUATE A UNAUTOUS WATERPROOFER IN A HUMAN RESIDENCE THE PROGNOSIS AND TO MONITOR THE PROGRESS OF A TREATMENT OF AN INDIVIDUAL, KIT TO EVALUATE THE SUSCETIBILITY FOR CANCER IN AN INDIVIDUAL, USE OF AN OLIGONUCLEOTIDE PROBE, MEDIA LEGIBLE BY COMPUTER, AND, DEVICE TO INDICATE A INDICATOR IN AN INDICATOR. .
JP2010508277A (en) 2006-11-01 2010-03-18 ジョージ メイソン インテレクチュアル プロパティーズ,インコーポレイテッド オブ フェアファックス,バージニア Methods for detecting and suppressing cancer
US20100196889A1 (en) 2006-11-13 2010-08-05 Bankaitis-Davis Danute M Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
US20080131887A1 (en) 2006-11-30 2008-06-05 Stephan Dietrich A Genetic Analysis Systems and Methods
US20100143935A1 (en) 2006-12-01 2010-06-10 Apocell, Inc. c-KIT Phosphorylation in Cancer
ES2923759T3 (en) 2006-12-14 2022-09-30 Life Technologies Corp Apparatus for measuring analytes using FET arrays
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US20080177608A1 (en) 2007-01-19 2008-07-24 Diaceutics Business method for enabling personalized medicine
JP2010528585A (en) 2007-02-26 2010-08-26 ジョン ウェイン キャンサー インスティテュート Usefulness of B-RAF DNA mutations in the diagnosis and treatment of cancer
EP2129397B1 (en) 2007-03-02 2018-10-31 Amgen, Inc. Methods and compositions for treating tumor diseases
WO2008112269A2 (en) 2007-03-13 2008-09-18 Amgen Inc. K-ras mutations and anti-egfr antibody therapy
WO2008112274A2 (en) 2007-03-13 2008-09-18 Amgen Inc. K-ras and b-raf mutations and anti-egfr antibody therapy
EP2140020A2 (en) 2007-03-15 2010-01-06 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
WO2008115556A2 (en) 2007-03-19 2008-09-25 Cold Spring Harbor Laboratory Identification of genetic alterations that modulate drug sensitivity in cancer treatments
WO2008127707A1 (en) 2007-04-13 2008-10-23 Dana Farber Cancer Institute, Inc. Receptor tyrosine kinase profiling
WO2008127716A2 (en) 2007-04-13 2008-10-23 George Mason Intellectual Properties, Inc. Stat3 as a theranostic indicator
WO2008147879A1 (en) 2007-05-22 2008-12-04 Ryan Golhar Automated method and device for dna isolation, sequence determination, and identification
WO2008148072A2 (en) 2007-05-24 2008-12-04 The Brigham And Women's Hospital, Inc. Disease-associated genetic variations and methods for obtaining and using same
CA2691364C (en) 2007-06-19 2020-06-16 Stratos Genomics, Inc. High throughput nucleic acid sequencing by expansion
GB0712882D0 (en) * 2007-07-03 2007-08-15 Leicester University Of Nucleic acid amplification
ES2526211T3 (en) 2007-07-13 2015-01-08 Nestec S.A. Selection of drugs for lung cancer therapy using antibody-based matrices
CA2694007C (en) 2007-07-23 2019-02-26 The Chinese University Of Hong Kong Determining a nucleic acid sequence imbalance
WO2009021019A1 (en) 2007-08-06 2009-02-12 Health Research Inc. Methods for analysis of pdef and survivin as interconnected cancer biomarkers and targets for personalized medicine
US20090062138A1 (en) 2007-08-31 2009-03-05 Curry Bo U Array-based method for performing SNP analysis
US20110212991A1 (en) 2007-09-11 2011-09-01 Roche Molecular Systems, Inc. Diagnostic Test for Susceptibility to B-RAF Kinase Inhibitors
US20100173294A1 (en) 2007-09-11 2010-07-08 Roche Molecular Systems, Inc. Diagnostic test for susceptibility to b-raf kinase inhibitors
US9388457B2 (en) * 2007-09-14 2016-07-12 Affymetrix, Inc. Locus specific amplification using array probes
WO2009039202A1 (en) * 2007-09-17 2009-03-26 Twof, Inc. Hydrogel labeled primer extension method for microarrays
JP2010539991A (en) 2007-10-04 2010-12-24 ハルシオン モレキュラー Sequencing of nucleic acid polymers using electron microscopy
EP2053132A1 (en) 2007-10-23 2009-04-29 Roche Diagnostics GmbH Enrichment and sequence analysis of geomic regions
US20090264298A1 (en) 2007-11-06 2009-10-22 Ambergen, Inc. Methods for enriching subpopulations
EP2063132A1 (en) * 2007-11-24 2009-05-27 Festo AG & Co. KG Linear drive device
EP2235217B1 (en) 2008-01-09 2016-04-20 Life Technologies Corporation Method of making a paired tag library for nucleic acid sequencing
WO2009091934A1 (en) 2008-01-17 2009-07-23 Sequenom, Inc. Single molecule nucleic acid sequence analysis processes and compositions
US11051733B2 (en) 2008-01-18 2021-07-06 Wake Forest University Health Sciences Isolating and purifying cells for therapy
US20110053157A1 (en) 2008-02-01 2011-03-03 The General Hospital Corporation Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
EP2245198A1 (en) 2008-02-04 2010-11-03 Massachusetts Institute of Technology Selection of nucleic acids by solution hybridization to oligonucleotide baits
WO2009102957A2 (en) 2008-02-14 2009-08-20 The Johns Hopkins University Methods to connect gene set expression profiles to drug sensitivity
WO2009101639A1 (en) 2008-02-14 2009-08-20 Decode Genetics Ehf. Susceptibility variants for lung cancer
NZ617520A (en) 2008-02-25 2015-05-29 Nestec Sa Drug selection for breast cancer therapy using antibody-based arrays
US20090226975A1 (en) * 2008-03-10 2009-09-10 Illumina, Inc. Constant cluster seeding
US8067178B2 (en) 2008-03-14 2011-11-29 Genomic Health, Inc. Gene expression markers for prediction of patient response to chemotherapy
US20090307180A1 (en) 2008-03-19 2009-12-10 Brandon Colby Genetic analysis
US7842248B2 (en) 2008-06-20 2010-11-30 Silverbrook Research Pty Ltd Microfluidic system comprising microfluidic pump, mixer or valve
WO2010003132A1 (en) 2008-07-02 2010-01-07 Illumina Cambridge Ltd. Using populations of beads for the fabrication of arrays on surfaces
US20100041048A1 (en) 2008-07-31 2010-02-18 The Johns Hopkins University Circulating Mutant DNA to Assess Tumor Dynamics
WO2010021936A1 (en) 2008-08-16 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Digital pcr calibration for high throughput sequencing
JP2010041985A (en) * 2008-08-18 2010-02-25 Hitachi Plant Technologies Ltd Method for amplifying nucleic acid sequence, method for detecting nucleic acid sequence and substrate for nucleic acid amplification and detection
EP3216874A1 (en) 2008-09-05 2017-09-13 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
CA2738578C (en) 2008-09-23 2021-05-04 Quantalife, Inc. Droplet-based assay system
EP3075864A1 (en) 2008-10-14 2016-10-05 Caris MPI, Inc. Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
US20100137143A1 (en) * 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US8349563B2 (en) 2008-11-18 2013-01-08 Life Technologies Corporation Sequence amplification with target primers
WO2010059742A1 (en) 2008-11-18 2010-05-27 Collabrx, Inc. Individualized cancer treatment
CA2747026A1 (en) 2008-12-17 2010-07-08 Life Technologies Corporation Methods, compositions, and kits for detecting allelic variants
US8790873B2 (en) 2009-01-16 2014-07-29 Affymetrix, Inc. DNA ligation on RNA template
CN102317475B (en) 2009-02-16 2014-07-16 阿霹震中科技公司 Template-independent ligation of single-stranded DNA
US20100286143A1 (en) 2009-04-24 2010-11-11 Dora Dias-Santagata Methods and materials for genetic analysis of tumors
DK2511843T3 (en) 2009-04-29 2017-03-27 Complete Genomics Inc METHOD AND SYSTEM FOR DETERMINING VARIATIONS IN A SAMPLE POLYNUCLEOTIDE SEQUENCE IN TERMS OF A REFERENCE POLYNUCLEOTIDE SEQUENCE
EP2470669B1 (en) 2009-08-25 2014-06-18 Illumina, Inc. Methods for selecting and amplifying polynucleotides
US10072287B2 (en) 2009-09-10 2018-09-11 Centrillion Technology Holdings Corporation Methods of targeted sequencing
EP2494069B1 (en) * 2009-10-30 2013-10-02 Roche Diagniostics GmbH Method for detecting balanced chromosomal aberrations in a genome
US20110117559A1 (en) 2009-11-13 2011-05-19 Integrated Dna Technologies, Inc. Small rna detection assays
EP2504448B1 (en) 2009-11-25 2016-10-19 Bio-Rad Laboratories, Inc. Methods and compositions for detecting genetic material
US8964013B2 (en) 2009-12-31 2015-02-24 Broadcom Corporation Display with elastic light manipulator
WO2011100604A2 (en) 2010-02-12 2011-08-18 Raindance Technologies, Inc. Digital analyte analysis
EP2539450B1 (en) 2010-02-25 2016-02-17 Advanced Liquid Logic, Inc. Method of making nucleic acid libraries
WO2011123749A1 (en) 2010-04-01 2011-10-06 New England Biolabs, Inc. Compositions and methods for adenylating oligonucleotides
WO2011140510A2 (en) 2010-05-06 2011-11-10 Bioo Scientific Corporation Oligonucleotide ligation, barcoding and methods and compositions for improving data quality and throughput using massively parallel sequencing
US20110299645A1 (en) 2010-06-07 2011-12-08 Korea Hydro & Nuclear Power Co., Ltd. Breeding Nuclear Fuel Mixture Using Metallic Thorium
US20120003657A1 (en) 2010-07-02 2012-01-05 Samuel Myllykangas Targeted sequencing library preparation by genomic dna circularization
US9376709B2 (en) 2010-07-26 2016-06-28 Biomatrica, Inc. Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures
EP3572528A1 (en) 2010-09-24 2019-11-27 The Board of Trustees of the Leland Stanford Junior University Direct capture, amplification and sequencing of target dna using immobilized primers
US9353406B2 (en) 2010-10-22 2016-05-31 Fluidigm Corporation Universal probe assay methods
JP5907990B2 (en) 2010-12-17 2016-05-11 ライフ テクノロジーズ コーポレーション Methods, compositions, systems, devices and kits for nucleic acid amplification
KR20210131432A (en) 2010-12-30 2021-11-02 파운데이션 메디신 인코포레이티드 Optimization of multigene analysis of tumor samples
WO2012103154A1 (en) 2011-01-24 2012-08-02 Nugen Technologies, Inc. Stem-loop composite rna-dna adaptor-primers: compositions and methods for library generation, amplification and other downstream manipulations
ES2625288T3 (en) 2011-04-15 2017-07-19 The Johns Hopkins University Secure Sequencing System
BR112014005205A2 (en) 2011-09-07 2017-03-21 X-Chem Inc methods for tagging dna encoded libraries
ES2729554T3 (en) 2011-10-21 2019-11-04 Chronix Biomedical Biomarkers of circulating nucleic acids associated with colorectal cancer
CA2862552A1 (en) 2012-01-26 2013-08-01 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
EP3584327A1 (en) 2012-01-27 2019-12-25 The Board of Trustees of the Leland Stanford Junior University Methods for profiling and quantitating cell-free rna
US20130203635A1 (en) 2012-02-06 2013-08-08 Ronald T. Raines Nucleic acid ligation method
WO2013173472A1 (en) 2012-05-15 2013-11-21 Predictive Biosciences, Inc. Methods of assessing chromosomal instabilities
US11261494B2 (en) 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
US9683230B2 (en) 2013-01-09 2017-06-20 Illumina Cambridge Limited Sample preparation on a solid support
WO2014110272A1 (en) 2013-01-09 2014-07-17 The Penn State Research Foundation Low sequence bias single-stranded dna ligation
EP2959016A4 (en) 2013-02-21 2016-10-12 Toma Biosciences Inc Methods, compositions, and kits for nucleic acid analysis
US20140287937A1 (en) 2013-02-21 2014-09-25 Toma Biosciences, Inc. Methods for assessing cancer
US9217167B2 (en) 2013-07-26 2015-12-22 General Electric Company Ligase-assisted nucleic acid circularization and amplification
CN104946737B (en) 2013-12-11 2019-02-22 安可济控股有限公司 For detecting the composition and method of rare sequence variants
US20190050530A1 (en) 2016-02-09 2019-02-14 Toma Biosciences, Inc. Systems and Methods for Analyzing Nucleic Acids

Similar Documents

Publication Publication Date Title
JP2013544498A5 (en)
US20220333160A1 (en) Methods for selectively suppressing non-target sequences
JP2022512058A (en) RNA depletion using nucleases
US10760123B2 (en) Sequential sequencing
Blumenstiel et al. Targeted exon sequencing by in‐solution hybrid selection
JP5986572B2 (en) Direct capture, amplification, and sequencing of target DNA using immobilized primers
JP6525473B2 (en) Compositions and methods for identifying replicate sequencing leads
US8986958B2 (en) Methods for generating target specific probes for solution based capture
JP5140425B2 (en) Method for simultaneously amplifying specific nucleic acids
Myllykangas et al. Efficient targeted resequencing of human germline and cancer genomes by oligonucleotide-selective sequencing
Krishnakumar et al. A comprehensive assay for targeted multiplex amplification of human DNA sequences
US20120045771A1 (en) Method for analysis of nucleic acid populations
US20070141604A1 (en) Method of target enrichment
EP3177740A1 (en) Digital measurements from targeted sequencing
JP2014507164A (en) Method and system for haplotype determination
CN111118125A (en) Method for purifying PCR product
JP6716465B2 (en) Sequencing of accumulated single cells
Karamitros et al. Multiplexed targeted sequencing for oxford nanopore MinION: a detailed library preparation procedure
JP2008502367A (en) Fast generation of oligonucleotides
CN111712580A (en) Method and kit for amplifying double-stranded DNA
Emerman et al. NEBNext direct: a novel, rapid, hybridization‐based approach for the capture and library conversion of genomic regions of interest
Igartua et al. Targeted enrichment of specific regions in the human genome by array hybridization
Mondal et al. Targeted sequencing of the human X chromosome exome
Mir et al. Sequencing by cyclic ligation and cleavage (CycLiC) directly on a microarray captured template
Goswami PCR techniques in next-generation sequencing